BACKGROUND: Chronic kidney disease (CKD) phenotypes such as albuminuria measured by urinary albumin creatinine ratio (ACR), elevated serum creatinine (SrCr) and/or decreased creatinine clearance (CrCl) and glomerular filtration rate (eGFR) are major risk factors for renal and cardiovascular diseases. Epidemiological studies have reported that CKD phenotypes cluster in families suggesting a genetic predisposition. However, studies reporting chromosomal regions influencing CKD are very limited. Therefore, the purpose of this study is to identify susceptible chromosomal regions for CKD phenotypes in Mexican American families enrolled in the San Antonio Family Heart Study (SAFHS). METHODS: We used the variance components decomposition approach (implemented in the software package SOLAR) to perform linkage analysis on 848 participants from 26 families. A total of 417 microsatellite markers were genotyped at an average interval of 10 cM spanning 22 autosomal chromosomes. RESULTS: All phenotypes were measured by standard procedures. Mean +/- SD values of ACR, SrCr, CrCl and eGFR were 0.06 +/- 0.38, 0.85 +/- 0.72 mg/dl, 129.85 +/- 50.37 ml/min and 99.18 +/- 25.69 ml/min/1.73 m(2) body surface area, respectively. All four CKD phenotypes exhibited significant heritabilities (P < 0.0001). A genome-wide scan showed linkage on chromosome 2p25 for SrCr, CrCl and eGFR. Significant linkage was also detected on chromosome 9q21 for eGFR [logarithm of the odds (LOD) score = 3.87, P = 0.00005] and SrCr (LOD score = 2.6, P = 0.00026). ACR revealed suggestive evidence for linkage to a region on chromosome 20q12 (LOD score = 2.93, P = 0.00020). CONCLUSION: Findings indicate that chromosomal regions 2p25, 9q21 and 20q12 may have functional relevance to CKD phenotypes in Mexican Americans.
BACKGROUND:Chronic kidney disease (CKD) phenotypes such as albuminuria measured by urinary albumin creatinine ratio (ACR), elevated serum creatinine (SrCr) and/or decreased creatinine clearance (CrCl) and glomerular filtration rate (eGFR) are major risk factors for renal and cardiovascular diseases. Epidemiological studies have reported that CKD phenotypes cluster in families suggesting a genetic predisposition. However, studies reporting chromosomal regions influencing CKD are very limited. Therefore, the purpose of this study is to identify susceptible chromosomal regions for CKD phenotypes in Mexican American families enrolled in the San Antonio Family Heart Study (SAFHS). METHODS: We used the variance components decomposition approach (implemented in the software package SOLAR) to perform linkage analysis on 848 participants from 26 families. A total of 417 microsatellite markers were genotyped at an average interval of 10 cM spanning 22 autosomal chromosomes. RESULTS: All phenotypes were measured by standard procedures. Mean +/- SD values of ACR, SrCr, CrCl and eGFR were 0.06 +/- 0.38, 0.85 +/- 0.72 mg/dl, 129.85 +/- 50.37 ml/min and 99.18 +/- 25.69 ml/min/1.73 m(2) body surface area, respectively. All four CKD phenotypes exhibited significant heritabilities (P < 0.0001). A genome-wide scan showed linkage on chromosome 2p25 for SrCr, CrCl and eGFR. Significant linkage was also detected on chromosome 9q21 for eGFR [logarithm of the odds (LOD) score = 3.87, P = 0.00005] and SrCr (LOD score = 2.6, P = 0.00026). ACR revealed suggestive evidence for linkage to a region on chromosome 20q12 (LOD score = 2.93, P = 0.00020). CONCLUSION: Findings indicate that chromosomal regions 2p25, 9q21 and 20q12 may have functional relevance to CKD phenotypes in Mexican Americans.
Authors: Andrew T DeWan; Donna K Arnett; Michael B Miller; James M Peacock; Larry D Atwood; Michael A Province; Cora E Lewis; Steven C Hunt; John H Eckfeldt Journal: Am J Hum Genet Date: 2002-07 Impact factor: 11.025
Authors: A T DeWan; D K Arnett; L D Atwood; M A Province; C E Lewis; S C Hunt; J Eckfeldt Journal: Am J Hum Genet Date: 2000-12-12 Impact factor: 11.025
Authors: Steven C Hunt; Sandra J Hasstedt; Hilary Coon; Nicola J Camp; Richard M Cawthon; Lily L Wu; Paul N Hopkins Journal: Kidney Int Date: 2002-10 Impact factor: 10.612
Authors: Madhumathi Rao; Amy K Mottl; Shelley A Cole; Jason G Umans; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Caroline S Fox; Qiong Yang; Adrienne Cupples; Sudha K Iyengar; Steven C Hunt; Thomas A Trikalinos Journal: Nephrol Dial Transplant Date: 2011-05-28 Impact factor: 5.992
Authors: Karen Hodgson; Russell A Poldrack; Joanne E Curran; Emma E Knowles; Samuel Mathias; Harald H H Göring; Nailin Yao; Rene L Olvera; Peter T Fox; Laura Almasy; Ravi Duggirala; Deanna M Barch; John Blangero; David C Glahn Journal: Cereb Cortex Date: 2017-12-01 Impact factor: 5.357
Authors: Carmen A Peralta; Yongmei Li; Christina Wassel; Shweta Choudhry; Walter Palmas; Michael F Seldin; Neil Risch; David Siscovick; Donna Arnett; Bruce Psaty; Michael G Shlipak Journal: Circ Cardiovasc Genet Date: 2010-05-05
Authors: Farook Thameem; V Saroja Voruganti; Xin He; Subrata D Nath; John Blangero; Jean W MacCluer; Anthony G Comuzzie; Hanna E Abboud; Nedal H Arar Journal: Hum Genet Date: 2008-11-06 Impact factor: 4.132
Authors: Cristian Pattaro; Alessandro De Grandi; Veronique Vitart; Caroline Hayward; Andre Franke; Yurii S Aulchenko; Asa Johansson; Sarah H Wild; Scott A Melville; Aaron Isaacs; Ozren Polasek; David Ellinghaus; Ivana Kolcic; Ute Nöthlings; Lina Zgaga; Tatijana Zemunik; Carsten Gnewuch; Stefan Schreiber; Susan Campbell; Nick Hastie; Mladen Boban; Thomas Meitinger; Ben A Oostra; Peter Riegler; Cosetta Minelli; Alan F Wright; Harry Campbell; Cornelia M van Duijn; Ulf Gyllensten; James F Wilson; Michael Krawczak; Igor Rudan; Peter P Pramstaller Journal: BMC Med Genet Date: 2010-03-11 Impact factor: 2.103